| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aileron Therapeutics Inc (NASDAQ: ALRN)
ALRN Technical Analysis
2.5
| As on 9th Jun 2023 ALRN SHARE Price closed @ 1.79 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.80 & Strong Buy for SHORT-TERM with Stoploss of 0.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALRNSHARE Price
| Open | 1.57 | Change | Price | % |
| High | 1.80 | 1 Day | 0.22 | 14.01 |
| Low | 1.55 | 1 Week | 0.31 | 20.95 |
| Close | 1.79 | 1 Month | 0.37 | 26.06 |
| Volume | 87400 | 1 Year | 1.24 | 225.45 |
| 52 Week High 67.30 | 52 Week Low 0.14 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALRN Daily Charts |
ALRN Intraday Charts |
Whats New @ Bazaartrend |
ALRN Free Analysis |
|
|
ALRN Important Levels Intraday
| RESISTANCE | 2.27 |
| RESISTANCE | 2.12 |
| RESISTANCE | 2.02 |
| RESISTANCE | 1.93 |
| SUPPORT | 1.65 |
| SUPPORT | 1.56 |
| SUPPORT | 1.46 |
| SUPPORT | 1.31 |
ALRN Forecast April 2024
| 4th UP Forecast | 2.14 |
| 3rd UP Forecast | 2.03 |
| 2nd UP Forecast | 1.96 |
| 1st UP Forecast | 1.89 |
| 1st DOWN Forecast | 1.69 |
| 2nd DOWN Forecast | 1.62 |
| 3rd DOWN Forecast | 1.55 |
| 4th DOWN Forecast | 1.44 |
ALRN Weekly Forecast
| 4th UP Forecast | 1.96 |
| 3rd UP Forecast | 1.91 |
| 2nd UP Forecast | 1.87 |
| 1st UP Forecast | 1.84 |
| 1st DOWN Forecast | 1.74 |
| 2nd DOWN Forecast | 1.71 |
| 3rd DOWN Forecast | 1.67 |
| 4th DOWN Forecast | 1.62 |
ALRN Forecast2024
| 4th UP Forecast | 137.82 |
| 3rd UP Forecast | 94.19 |
| 2nd UP Forecast | 67.23 |
| 1st UP Forecast | 40.26 |
| 1st DOWN Forecast | -36.68 |
| 2nd DOWN Forecast | -63.65 |
| 3rd DOWN Forecast | -90.61 |
| 4th DOWN Forecast | -134.24 |
Aileron Therapeutics Inc ( NASDAQ USA Symbol : ALRN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALRN Business Profile
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. Aileron Therapeutics, Inc. has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts. Address: 285 Summer Street, Boston, MA, United States, 02210
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service